Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deucravacitinib in Lupus Nephritis (Phase 2, China)
CTR20200316Phase 2Terminated
- Sponsor
- Bristol Myers Squibb
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of deucravacitinib in lupus nephritis (LN), sponsored by Bristol Myers Squibb. Started Mar 2020; status: terminated.
02
Drugs
deucravacitinib
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on CTR20200316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200316.